基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the detailed record of transactions filed by Gibney Anthony S. Director active across 3 companies, notably IVERIC bio, Inc.. Aggregated, 10 disclosures have been published. Split: 2 buys · 2 sells. Total volume traded: €234k. Activity tracked since 30 June 2022. The latest transaction was disclosed on 2 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Gibney Anthony S is associated with Aura Biosciences, Inc., IVERIC bio, Inc. and Clearside Biomedical, Inc., with the roles listed in the data block. Across 10 total filings, the sampled recent filings cover the period from 2022-07-05 to 2026-06-16, with EUR 226754 in buys and EUR 6989 in sells, and the most common transaction nature is Cession.